242 related articles for article (PubMed ID: 34124275)
1. Identification of CD8+ T Cell-Related Genes: Correlations with Immune Phenotypes and Outcomes of Liver Cancer.
Pan Q; Cheng Y; Cheng D
J Immunol Res; 2021; 2021():9960905. PubMed ID: 34124275
[TBL] [Abstract][Full Text] [Related]
2. Tumor Purity Coexpressed Genes Related to Immune Microenvironment and Clinical Outcomes of Lung Adenocarcinoma.
Bai M; Pan Q; Sun C
J Oncol; 2021; 2021():9548648. PubMed ID: 34234827
[TBL] [Abstract][Full Text] [Related]
3. CD8
Jiang J; Zhao Y
J Oncol; 2021; 2021():5533923. PubMed ID: 33854546
[TBL] [Abstract][Full Text] [Related]
4. 9-Gene Signature Correlated With CD8
Yan K; Lu Y; Yan Z; Wang Y
Front Immunol; 2021; 12():622563. PubMed ID: 34220795
[TBL] [Abstract][Full Text] [Related]
5. Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome.
Yan K; Wang Y; Lu Y; Yan Z
J Immunol Res; 2021; 2021():6664791. PubMed ID: 33748290
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma.
Cao L; Liu M; Ma X; Rong P; Zhang J; Wang W
Curr Med Chem; 2024; 31(17):2414-2430. PubMed ID: 37936457
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
[TBL] [Abstract][Full Text] [Related]
8. CD8+ T Cell Co-Expressed Genes Correlate With Clinical Phenotype and Microenvironments of Urothelial Cancer.
Wang Y; Yan K; Lin J; Liu Y; Wang J; Li X; Li X; Hua Z; Zheng Z; Shi J; Sun S; Bi J
Front Oncol; 2020; 10():553399. PubMed ID: 33330025
[TBL] [Abstract][Full Text] [Related]
9. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
Hou Y; Zhang G
Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
[TBL] [Abstract][Full Text] [Related]
10. PD1
Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
[TBL] [Abstract][Full Text] [Related]
11. 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8
Kim HD; Park S; Jeong S; Lee YJ; Lee H; Kim CG; Kim KH; Hong SM; Lee JY; Kim S; Kim HK; Min BS; Chang JH; Ju YS; Shin EC; Song GW; Hwang S; Park SH
Hepatology; 2020 Mar; 71(3):955-971. PubMed ID: 31353502
[TBL] [Abstract][Full Text] [Related]
12. Cancer cell-intrinsic STING is associated with CD8 + T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma.
Zhang Y; Zhai Q; Feng X; Chen D; Lu Y; Hu J; Xie H; Zhou L; Wu J; Zheng S
Clin Transl Oncol; 2021 Jul; 23(7):1314-1324. PubMed ID: 33502741
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.
Zhang HH; Mei MH; Fei R; Liao WJ; Wang XY; Qin LL; Wang JH; Wei L; Chen HS
Int J Oncol; 2010 Apr; 36(4):841-8. PubMed ID: 20198327
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment.
Zhu Z; Ye W; Wu X; Lin S; Xu J; Li L; Li J; Wang H; Huang Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33350431
[TBL] [Abstract][Full Text] [Related]
15. CD74
Xiao N; Li K; Zhu X; Xu B; Liu X; Lei M; Sun HC
Cancer Immunol Immunother; 2022 Jan; 71(1):57-69. PubMed ID: 34009409
[TBL] [Abstract][Full Text] [Related]
16. SSRP1 Is a Prognostic Biomarker Correlated with CD8
Luo G; Xu J; Xia Z; Liu S; Liu H; He K; Xiang G
Biomed Res Int; 2021; 2021():9409836. PubMed ID: 33688504
[TBL] [Abstract][Full Text] [Related]
17. T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.
Ma W; Chen X; Yuan Y
Immunotherapy; 2017 Jun; 9(7):523-525. PubMed ID: 28595519
[No Abstract] [Full Text] [Related]
18. Holliday Cross-Recognition Protein
Luo D; Liao S; Liu Y; Lin Y; Li Y; Liao X
Pathol Oncol Res; 2022; 28():1610506. PubMed ID: 35783358
[No Abstract] [Full Text] [Related]
19. Identification of biomarkers related to CD8
Lin J; Yu M; Xu X; Wang Y; Xing H; An J; Yang J; Tang C; Sun D; Zhu Y
Aging (Albany NY); 2020 Feb; 12(4):3694-3712. PubMed ID: 32081834
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of CD8
Pu Q; Yu L; Liu X; Yan H; Xie Y; Cai X; Wu Y; Du J; Yang Z
Front Immunol; 2024; 15():1375864. PubMed ID: 38650927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]